In today’s recent session, 0.86 million shares of the Palisade Bio Inc (NASDAQ:PALI) have been traded, and its beta is 1.38. Most recently the company’s share price was $0.70, and it changed around -$0.09 or -10.42% from the last close, which brings the market valuation of the company to $3.10M. PALI at last check was trading at a discount to its 52-week high of $8.57, offering almost -1124.29% off that amount. The share price’s 52-week low was $0.60, which indicates that the recent value has risen by an impressive 14.29% since then.
Palisade Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended PALI as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Palisade Bio Inc (NASDAQ:PALI) trade information
Instantly PALI has been showing red trend so far today with a performance of -10.42% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8300 on recent trading dayincreased the stock’s daily price by 15.66%. The company’s shares are currently down -57.27% year-to-date, but still down -6.70% over the last five days. On the other hand, Palisade Bio Inc (NASDAQ:PALI) is -1.34% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $1.5, which translates to bulls needing to increase their stock price by 53.33% from its current value. Analyst projections state that PALI is forecast to be at a low of $1.5 and a high of $1.5.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 77.35%. Palisade Bio Inc earnings are expected to increase by 82.17% in 2025, but the outlook is positive 53.17% per year for the next five years.
PALI Dividends
Palisade Bio Inc’s next quarterly earnings report is expected to be released in June.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 6.22 shares worth $4357.0, making up 0.14% of all outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held roughly 4.54 shares worth around $3177.0, which represents about 0.10% of the total shares outstanding.
